Sunovion Pharmaceuticals. M&A Summary
Sunovion Pharmaceuticals. has acquired 2 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.
Sunovion Pharmaceuticals.’s largest acquisition to date was in 2016, when it acquired Cynapsus Therapeutics for $624M. It’s largest disclosed sale occurred in 2014, when it sold Xopenex Inhalation Solution to Akorn for $45M. Sunovion Pharmaceuticals. has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (100%).
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity2
- M&A Sell Activity2
- Total Sectors Invested 1
- Total Countries Invested 2
- M&A Buy/Sell Connections 3
Unlimited Searches
